Michael Abrams - Sep 27, 2021 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTH)

Role
Chief Financial Officer
Signature
/s/ Michael Abrams
Stock symbol
ARTH
Transactions as of
Sep 27, 2021
Transactions value $
$0
Form type
4
Date filed
10/1/2021, 08:17 AM
Previous filing
May 10, 2021
Next filing
Jul 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTH Stock Option (right to buy) Award $0 +350K $0.00 350K Sep 27, 2021 Common Stock 350K $0.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Michael Abrams is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.